Posts

Obesity – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036

Obesity Market Outlook Thelansis’s “Obesity Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Obesity treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Obesity Overview Obesity is a complex, chronic, neurobehavioral disease characterized by excessive accumulation of body fat that impairs health and elevates the risk of comorbidities like type 2 diabetes, cardiovascular disease, and certain cancers. Rather than a simple calorie imbalance, it is driven by dysregulation of neuroendocrine pathways controlling energy homeostasis and appetite. Diagnosis historically relies on a body mass index of 30 or higher, though clinical focus ...
Post a Comment
Read more

Stargardt Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036

Stargardt Disease Market Outlook Thelansis’s “Stargardt Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2026 To 2036” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Stargardt Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Stargardt Disease Overview Stargardt disease is a rare, inherited macular dystrophy that leads to progressive central vision loss, typically beginning in childhood or adolescence, and is most commonly caused by mutations in the ABCA4 gene. This genetic defect disrupts the normal transport of vitamin A derivatives in photoreceptor cells, resulting in the accumulation of toxic lipofuscin within the retinal pigment epithelium, which damages the macula...
Post a Comment
Read more

Prostate Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Prostate Cancer Market Outlook Thelansis’s “Prostate Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Prostate Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Prostate Cancer Overview Prostate cancer is the most common malignancy in men, arising from prostatic glandular epithelium driven by androgen receptor signalling, with somatic alterations in PTEN, TP53, RB1, and DNA repair genes including BRCA1, BRCA2, and CDK12 underpinning aggressive and castration-resistant disease biology. Patients present with urinary symptoms, elevated PSA, or incidentally detected nodules, with many diagnosed through PSA-based scr...
Post a Comment
Read more

Idiopathic Hypersomnia (IH) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Idiopathic Hypersomnia (IH) Market Outlook Thelansis’s “Idiopathic Hypersomnia (IH) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Idiopathic Hypersomnia (IH) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Idiopathic Hypersomnia (IH) Overview Idiopathic hypersomnia (IH) is a chronic central hypersomnolence disorder characterised by excessive daytime sleepiness, prolonged non-restorative nocturnal sleep, and severe sleep inertia despite adequate or extended sleep opportunity, occurring without identifiable underlying aetiology or narcolepsy-defining features. The pathophysiology implicates enhanced GABAergic inhibitory to...
Post a Comment
Read more

Junctional Epidermolysis Bullosa (JEB) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Junctional Epidermolysis Bullosa (JEB) Market Outlook Thelansis’s “Junctional Epidermolysis Bullosa (JEB) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Junctional Epidermolysis Bullosa (JEB) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Junctional Epidermolysis Bullosa (JEB) Overview Junctional epidermolysis bullosa (JEB) is a rare, potentially life-threatening autosomal recessive mechanobullous disorder caused by mutations in genes encoding laminin-332 (LAMA3, LAMB3, LAMC2) and collagen XVII (COL17A1), disrupting hemidesmosomal anchoring at the lamina lucida level of the dermal-epidermal junction and producing charact...
Post a Comment
Read more

Dystrophic Epidermolysis Bullosa – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Dystrophic Epidermolysis Bullosa Market Outlook Thelansis’s “Dystrophic Epidermolysis Bullosa Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Dystrophic Epidermolysis Bullosa treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Dystrophic Epidermolysis Bullosa Overview Dystrophic epidermolysis bullosa (DEB) is a severe hereditary mechanobullous disorder caused by mutations in the COL7A1 gene, which encodes type VII collagen, the primary component of anchoring fibrils securing the epidermis to the dermis. Inherited in either autosomal dominant or recessive patterns, the resulting deficiency or structural defect in type VII colla...
Post a Comment
Read more

Sepsis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Sepsis Market Outlook Thelansis’s “Sepsis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Sepsis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Sepsis Overview Sepsis is a life-threatening medical emergency defined as acute organ dysfunction caused by a dysregulated host immune response to an infection. Driven predominantly by bacterial pathogens, though occasionally by viruses or fungi, the pathobiology involves widespread endothelial injury, microvascular thrombosis, capillary leak, and impaired cellular oxygen utilization. Diagnostically, the Sepsis-3 framework utilizes an acute increase of two or more points in the Se...
Post a Comment
Read more